Cargando…

SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma

BACKGROUND: The absence of prominent, actionable genetic alternations in osteosarcomas (OS) implies that transcriptional and epigenetic mechanisms significantly contribute to the progression of this life-threatening form of cancer. Therefore, the identification of potential transcriptional events th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Young-Im, Tseng, Yu-Chou, Ayaz, Gamze, Wang, Shasha, Yan, Hualong, du Bois, Wendy, Yang, Howard, Zhen, Tao, Lee, Maxwell P., Liu, Paul, Kaplan, Rosandra N., Huang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367263/ https://www.ncbi.nlm.nih.gov/pubmed/37491298 http://dx.doi.org/10.1186/s13578-023-01088-2

Ejemplares similares

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer
por: Malik, Navdeep, et al.
Publicado: (2021)

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
por: Decaesteker, Bieke, et al.
Publicado: (2023)

The Role of RUNX2 in Osteosarcoma Oncogenesis
por: Martin, J. W., et al.
Publicado: (2011)

Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes
por: Orfanidou, Timoklia, et al.
Publicado: (2009)

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis
por: Roos, Alison, et al.
Publicado: (2015)

Interleukin-6 upregulates SOX18 expression in osteosarcoma
por: Wu, Zhong, et al.
Publicado: (2017)

Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma
por: Yang, Jilong, et al.
Publicado: (2013)

An Immunohistochemistry Study of Sox9, Runx2, and Osterix Expression in the Mandibular Cartilages of Newborn Mouse
por: Zhang, Hong, et al.
Publicado: (2013)

Dmrt2 promotes transition of endochondral bone formation by linking Sox9 and Runx2
por: Ono, Koichiro, et al.
Publicado: (2021)

Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension
por: Simmons Beck, Robert, et al.
Publicado: (2023)

Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function
por: Del Mare, Sara, et al.
Publicado: (2015)

LncRNA TUG1 promotes the development of osteosarcoma through RUNX2
por: Sheng, Kunkun, et al.
Publicado: (2019)

miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1–Sox2 axis
por: Zhang, Yu, et al.
Publicado: (2018)

The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
por: Fernando, Thilini R., et al.
Publicado: (2017)

Sox2 maintains self-renewal of tumor initiating cells in osteosarcomas
por: Basu-Roy, Upal, et al.
Publicado: (2011)

Sox2 is required for tumor development and cancer cells proliferation in osteosarcoma
por: Maurizi, Giulia, et al.
Publicado: (2018)

Pharmacological Inhibition of Core Regulatory Circuitry Liquid–liquid Phase Separation Suppresses Metastasis and Chemoresistance in Osteosarcoma
por: Lu, Bing, et al.
Publicado: (2021)

Nell-1, a key Functional Mediator of Runx2, Partially Rescues Calvarial Defects in Runx2(+/−) Mice
por: Zhang, Xinli, et al.
Publicado: (2011)

Corticostriatal circuitry
por: Haber, Suzanne N.
Publicado: (2016)

The circuitry of sex
por: Levine, Joel
Publicado: (2016)

Terminal osteoblast differentiation, mediated by runx2 and p27(KIP1), is disrupted in osteosarcoma
por: Thomas, David M., et al.
Publicado: (2004)

MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2
por: Xie, Yuanlong, et al.
Publicado: (2017)

MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2
por: Zhang, Can, et al.
Publicado: (2021)

Datasets for the effects of RUNX2 silencing on transcriptomic and metabolomic profiles in SJSA-1 osteosarcoma cells
por: Le, Mai Nhu Uyen, et al.
Publicado: (2023)

Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis
por: Zhu, Haibo, et al.
Publicado: (2013)

Increased Gene Expression of RUNX2 and SOX9 in Mesenchymal Circulating Progenitors Is Associated with Autophagy during Physical Activity
por: Dalle Carbonare, L., et al.
Publicado: (2019)

Dexamethasone Induces Changes in Osteogenic Differentiation of Human Mesenchymal Stromal Cells via SOX9 and PPARG, but Not RUNX2
por: Della Bella, Elena, et al.
Publicado: (2021)

cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma
por: He, Yunlong, et al.
Publicado: (2017)

The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular properties
por: Dy, Peter, et al.
Publicado: (2008)

miR-126 Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox2
por: Yang, Chenglin, et al.
Publicado: (2013)

Transistors, theory and circuitry
por: Dean, Kenneth John
Publicado: (1964)

Brain serotonergic circuitries
por: Charnay, Yves, et al.
Publicado: (2010)

The Dynamics of Striatum Circuitry
por: Lin, Shih-Chieh
Publicado: (2010)

Typical oscilloscope circuitry
por: Tektronix. Beaverton
Publicado: (1962)

BEBC control circuitry
Publicado: (1977)

Structural mechanism of DNA-mediated Nanog–Sox2 cooperative interaction
por: Yesudhas, Dhanusha, et al.
Publicado: (2019)

miR-3195 suppresses the malignant progression of osteosarcoma cells via targeting SOX4
por: Liang, Jianwei, et al.
Publicado: (2023)

Implant surface treatments affect gene expression of Runx2, osteogenic key marker
por: Na, Young, et al.
Publicado: (2009)

Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy
por: Sadikovic, Bekim, et al.
Publicado: (2010)

MicroRNA-150 functions as a tumor suppressor and sensitizes osteosarcoma to doxorubicin-induced apoptosis by targeting RUNX2
por: Ling, Zhonghua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5kkct3vh2rqodiidnpn5q0n6ti